Janux Therapeutics (JANX) - News Mentions

Sign up to add (JANX) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 1 0%
Gilead Sciences
Gilead Sciences
GILD		 0 100%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Janux Therapeutics (JANX) Gets Initiated With a Buy Rating at Truist Financial
October 20
Why Janux Therapeutics (JANX) Is Up 10.5% After Pipeline Progress Fuels Optimism for Prostate Cancer Therapies
October 10
Janux Therapeutics (JANX) Surges 6.8%: Is This an Indication of Further Gains?
October 10
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Average Rating of “Moderate Buy” from Brokerages
October 3
Rhumbline Advisers Buys 4,497 Shares of Janux Therapeutics, Inc. $JANX
September 20
Janux Therapeutics (NASDAQ:JANX) Earns Overweight Rating from Analysts at Barclays
September 18
Janux Therapeutics initiated with bullish view at Barclays, here's why
September 16
Janux Therapeutics initiated with bullish view at Barclays
September 16
Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT
September 15
Janux Therapeutics (NASDAQ:JANX) Now Covered by Truist Financial
September 11
Janux Therapeutics initiated with bullish view at Truist, here's why
September 10
Janux Therapeutics resumed with a Buy at Stifel
September 10
Janux Therapeutics, Inc. $JANX Stock Position Raised by MetLife Investment Management LLC
September 8
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $86.90 Average Target Price from Analysts
September 6
Janux Therapeutics initiated with bullish view at Guggenheim, here's why
September 4
Walleye Capital LLC Invests $307,000 in Janux Therapeutics, Inc. $JANX
September 4

Month over Month

Est. daily news mentions.

Sep 2025 0
Aug 2025 0
Jul 2025 0
Jun 2025 0
May 2025 1

How often is Janux Therapeutics mentioned in the news?

Janux Therapeutics was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Janux Therapeutics performing compared to its industry peers?

Janux Therapeutics underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Janux Therapeutics in the last month?

There has been no significant change in the number of news mentions for Janux Therapeutics' compared to the last month.

Why is it important to track news mentions for Janux Therapeutics?

By monitoring mentions in the news for Janux Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Janux Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on Janux Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
House & Congress Trading
Earnings Calendar
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.